Genetic Variability of the SARS-CoV-2 Pocketome

Abstract excerpt

In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to interferon and immune responses
• Share to RNA and protein synthesis mechanisms
• Share to SARS-CoV-2 and COVID-19 Research